OrthoPediatrics Corp. (KIDS)
NASDAQ: KIDS · IEX Real-Time Price · USD
32.57
-1.14 (-3.38%)
At close: Jul 19, 2024, 4:00 PM
32.59
+0.02 (0.06%)
Pre-market: Jul 20, 2024, 9:26 AM EDT
OrthoPediatrics Revenue
OrthoPediatrics had revenue of $161.83M in the twelve months ending March 31, 2024, with 24.04% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $44.69M with 41.46% year-over-year growth. In the year 2023, OrthoPediatrics had annual revenue of $148.73M with 21.62% growth.
Revenue (ttm)
$161.83M
Revenue Growth
+24.04%
P/S Ratio
4.80
Revenue / Employee
$655,178
Employees
247
Market Cap
776.11M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 148.73M | 26.44M | 21.62% |
Dec 31, 2022 | 122.29M | 24.24M | 24.72% |
Dec 31, 2021 | 98.05M | 26.97M | 37.95% |
Dec 31, 2020 | 71.08M | -1.47M | -2.03% |
Dec 31, 2019 | 72.55M | 14.99M | 26.05% |
Dec 31, 2018 | 57.56M | 11.94M | 26.17% |
Dec 31, 2017 | 45.62M | 8.32M | 22.31% |
Dec 31, 2016 | 37.30M | 6.29M | 20.30% |
Dec 31, 2015 | 31.00M | 7.32M | 30.91% |
Dec 31, 2014 | 23.68M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Embecta | 1.13B |
Phibro Animal Health | 999.56M |
Evolus | 219.70M |
Aurinia Pharmaceuticals | 191.41M |
Travere Therapeutics | 183.23M |
Simulations Plus | 66.98M |
Abivax | 5.13M |
Dianthus Therapeutics | 2.26M |
KIDS News
- 6 weeks ago - OrthoPediatrics Corp. to Participate in the Truist Securities MedTech Conference - GlobeNewsWire
- 2 months ago - OrthoPediatrics Corp. Continued Leading Sponsorship at 2024 EPOSNA Annual Meeting - GlobeNewsWire
- 2 months ago - OrthoPediatrics Corp. Reports First Quarter 2024 Financial Results and Increases Full Year 2024 Revenue Guidance - GlobeNewsWire
- 3 months ago - OrthoPediatrics Corp. to Report First Quarter 2024 Financial Results on May 7, 2024 - GlobeNewsWire
- 3 months ago - OrthoPediatrics Corp. to Highlight its Pediatric Scoliosis Solutions at 8th Annual International Children's Spine Symposium (ICSS) - GlobeNewsWire
- 4 months ago - OrthoPediatrics Corp. to Participate in the 23rd Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 4 months ago - OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 4 months ago - OrthoPediatrics Corp. Launches New RESPONSE Rib and Pelvic Fixation System for EOS Scoliosis - GlobeNewsWire